Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
02/1998
02/17/1998US5719169 Substituted benzoylguanidines, their use as a medicament or diagnostic, and medicament containing them
02/17/1998US5719164 Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
02/17/1998US5719163 Arthritis
02/17/1998US5719149 Morpholine derivatives and their use as therapeutic agents
02/17/1998US5719143 Polysubstituted 3-acylamino-5-phenyl-1, 4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them
02/17/1998US5719140 2, 3-, 4-, 5-, 6-, 7-, 8-, 9- and /or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
02/17/1998US5719136 Combination of progesterone antagonists and antiestrogens with partial agonistic action for hormone substitution therapy for perimenopausal and postmenopausal women
02/17/1998US5719135 Tyrosine kinase inhibitors
02/17/1998US5719129 Sunscreen agents, antiaging agent, free radical scavenger
02/17/1998US5719125 Human chondromodulin-I protein
02/17/1998US5718897 Contacting with purified clostridiopeptidase a collagenase and a growth factor to increase effects of collagenase
02/17/1998CA1339679C Reduced size lhrh analogs
02/12/1998WO1998005792A2 A novel human leptin receptor gene-related protein
02/12/1998WO1998005783A1 A tumor necrosis factor related ligand
02/12/1998WO1998005782A1 Testis-specific insulin homolog polypeptides
02/12/1998WO1998005776A2 Secreted proteins and polynucleotides encoding them
02/12/1998WO1998005761A1 Age-1 polypeptides and related molecules and methods
02/12/1998WO1998005661A1 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
02/12/1998WO1998005642A1 Cftr channel activator compounds and pharmaceutical compositions containing same
02/12/1998WO1998005637A1 Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a¿2?
02/12/1998WO1998005635A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
02/12/1998WO1998005361A2 Long-acting drugs and pharmaceutical compositions comprising them
02/12/1998WO1998005350A1 Materials and methods for treatment of plaquing diseases
02/12/1998WO1998005349A1 A novel method of detecting and treating cancer
02/12/1998WO1998005347A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof
02/12/1998WO1998005343A1 Anti-stress drugs and functional foods having anti-stress effects
02/12/1998WO1998005341A1 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus
02/12/1998WO1998005338A2 Use of a dehydroepiandrosterone derivative for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue
02/12/1998WO1998005336A1 Inhibitors of cysteine protease
02/12/1998WO1998005333A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
02/12/1998WO1998005329A1 Il-8 receptor antagonists
02/12/1998WO1998005328A1 Il-8 receptor antagonists
02/12/1998WO1998005317A1 Il-8 receptor antagonists
02/12/1998WO1997044354A3 Synthesis of soluble beta-sheet forming peptides
02/12/1998DE19642872C1 Use of sterol sulphate compounds to inhibit serine protease
02/12/1998CA2263154A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
02/12/1998CA2262900A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
02/12/1998CA2262624A1 A novel method of detecting and treating cancer
02/12/1998CA2262399A1 Secreted proteins and polynucleotides encoding them
02/12/1998CA2262223A1 Novel carbocyclic diarylmethylene derivatives, methods for preparing same, and therapeutical uses thereof
02/12/1998CA2261783A1 1,2-diarylindole as cox-2 inhibitors
02/12/1998CA2261742A1 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus
02/12/1998CA2261573A1 A novel human leptin receptor gene-related protein
02/12/1998CA2260742A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof
02/12/1998CA2233987A1 Materials and methods for treatment of plaquing diseases
02/11/1998EP0823478A2 Human cartilage gp 39-like gene
02/11/1998EP0823437A2 8-Substituted B-nor-6-thiaequilenin compounds having activity as selective estrogen receptor modulators
02/11/1998EP0822986A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds
02/11/1998EP0822983A1 Apopain
02/11/1998EP0822934A1 Antithrombotic amidinotetrahydropyridylalanine derivatives
02/11/1998EP0822932A1 Piperidine derivatives as diuretic
02/11/1998EP0822830A1 Human antibodies derived from immunized xenomice
02/11/1998EP0822826A1 Nitrosylated neuropeptides
02/11/1998EP0822820A1 NOVEL USE OF (S)-ADENOSYL-L-METHIONINE (SAMe)
02/11/1998EP0776323B1 Salts of an anti-migraine indole derivative
02/11/1998CN1173179A Substituted 2 -(phosphinyloxymethyl) -1, 2, 5 -thiadiazolidin -3 -one 1, 1 -dioxides and compositions and method of use thereof
02/11/1998CN1173176A 2 -substituted 1, 2, 5 -thiadiazolidin-3 -one 1, 1-dioxides and compositions and method of use thereof
02/11/1998CN1173175A Substituted 2 -arylcaronyloxymethyl -1, 2, 5 -thiadiazolidin -3 -one 1, 1-dioxide derivatives and compositions and method of use thereof
02/11/1998CN1173174A Substituted oxazolidine calpain and/or cathepsin B inhibitors
02/11/1998CN1173170A Matrix metalloprotease inhibitors
02/11/1998CN1173132A Dihydropyrimidines and uses thereof
02/11/1998CN1173131A 2 -(2, 3, 5, 6 -tetrafluoro -4 -phridyl) -1, 2, 5 -thiadiazolidin -3 -one 1, 1 -dioxides and compositions and method of use thereof
02/11/1998CN1173130A 2 -heterocyclyloxy and thiomethyl -1, 2, 5 -thiadiazolidin -3 -one 1, 1 -dioxides and compositions and method of use thereof
02/11/1998CN1172801A Fluorinated vitamin D3 analogs
02/11/1998CN1172669A Method for extracting and separating flavone and terlactone from ginkgo leaf by supercritical carbon dioxide
02/11/1998CN1172668A Method for removing phenolic acid from ginkgo leaf extract by supercritical carbon dioxide
02/11/1998CN1172665A Chinese medicinal herb preparation for eliminating human body medicine and waste residuum
02/11/1998CN1172649A Hair regrowth liniment and its preparation method
02/11/1998CN1172614A Antioxidant composition and method for production thereof
02/11/1998CN1037347C Method for preparation polytehoxylated vitamin E
02/10/1998US5717102 Psychotherapeutics; headaches
02/10/1998US5717092 Compounds with improved multi-drug resistance activity
02/10/1998US5717083 Phosphoramidate and phosphorothiomidate oligomeric compounds
02/10/1998US5717062 Cyclic analogs of PTH and PTHrP
02/10/1998US5716982 Retinoids and methods of use of same
02/10/1998US5716980 Alcohol or aldehyde derivatives and their use
02/10/1998US5716979 Tachykinin antagonists
02/10/1998US5716973 Anti-viral compounds
02/10/1998US5716970 Diuretic compound
02/10/1998US5716967 Isoxazoline compounds as antiinflammatory agents
02/10/1998US5716966 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
02/10/1998US5716959 Administering substituted piperazines having hydroxy- or amino-alkyl groups on one nitrogen and carboxylic, phosphoric or sulfonic alkyl groups on the other nitrogen, for treatment of cancer and autoimmune diseases
02/10/1998US5716956 Dihydrophthalazine antagonists of excitatory amino acid receptors
02/10/1998US5716955 Cytokine inhibitor
02/10/1998US5716949 Heterocyclic compounds
02/10/1998US5716945 Antiinflammatory agents; immunostimulation; cell differentiation; antigrowth agents
02/10/1998US5716943 Phosphinic acid derivatives with metallopeptidase inhibitory activity
02/10/1998US5716936 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders
02/10/1998US5716935 Applying polypeptide in carrier to wound to accelerate healing
02/10/1998US5716934 Eck receptor ligands
02/10/1998US5716929 Inhibitors of interleukin-1β converting enzyme
02/10/1998US5716612 Desensitizing the cancer cell drug resistance
02/10/1998CA2079205C Use of hyaluronic acid and forms to prevent arterial restenosis
02/10/1998CA1339661C Cycloalkylamides of (8b)-1alkyl-6 (substituted)ergolines
02/06/1998CA2212204A1 8-substituted b-nor-6-thiaequilenin compounds having activity as selective estrogen receptor modulators
02/05/1998WO1998004734A1 Synthetic protein folding catalysis
02/05/1998WO1998004709A2 Herpes simplex virus icp4 is an inhibitor of apoptosis
02/05/1998WO1998004694A2 Secreted proteins and polynucleotides encoding them
02/05/1998WO1998004691A1 Human proteolipid
02/05/1998WO1998004686A2 Pro-protein converting enzyme